Status:
COMPLETED
Evaluation of a Web-Based Intervention for Bulimia Nervosa
Lead Sponsor:
Heidelberg University
Collaborating Sponsors:
Selfapy GmbH
Conditions:
Bulimia Nervosa
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study evaluates the effectiveness of a web-based intervention specifically designed for patients with Bulimia Nervosa (BN) in a blinded randomized controlled trial. After a sign-up process, a di...
Detailed Description
Background: Bulimia Nervosa (BN) is characterized by persistent episodes of uncontrolled eating and inappropriate compensatory behaviors, associated with marked impairments in physical and mental heal...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- sufficient German language skills (C1)
- permanent internet access during the study period
- meeting the diagnostic criteria for Bulimia Nervosa according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
- Exclusion criteria:
- current severe depressive episode
- acute suicidality
- comorbid bipolar disorder or psychotic disorders
- acute substance dependence
- current psychotherapy or pharmacotherapy for eating disorders
- Body Mass Index (BMI) below 18.5
Exclusion
Key Trial Info
Start Date :
January 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 7 2022
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT04876196
Start Date
January 12 2021
End Date
July 7 2022
Last Update
March 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Heidelberg University
Heidelberg, Baden-Wurttemberg, Germany, 69117